Core Viewpoint - Madrid is urging prosecutors to investigate social media platforms for potential crimes against minors related to the distribution of AI-generated images [1] Group 1 - The investigation focuses on the implications of AI-generated content on minors [1] - Authorities are concerned about the impact of such content on child safety and well-being [1] - The request highlights the growing scrutiny of social media platforms regarding their responsibility in protecting vulnerable users [1]

Investors start to see past Trump and ask which takeover offer is really better. ...

The company said it now expects full-year revenue to come in between $11.28 billion and $11.31 billion, up from a range of $10.5 billion to $10.54 billion. ...

The furniture maker logged higher third-quarter sales amid growth in its retail and wholesale segments, partially offset by a decline for its Joybird brand. ...

Core Insights - In Warren Buffett's final quarter as CEO, the company reduced its stake in the iPhone manufacturer [1] Group 1 - The company further trimmed its holdings in the iPhone maker during this period [1]

Group 1 - Amazon.com and Nvidia recovered from early losses to end the trading day positively [1] - The three major stock indexes each experienced a rise of 0.1% [1]

Group 1 - The betting company reported a decrease in profit compared to the prior-year quarter [1] - The decline in profit was primarily attributed to gains on asset sales exceeding $350 million in the previous year [1]

Group 1 - The job market is described as "especially vulnerable to negative shocks" due to low levels of job creation and a low firing rate [1]

Group 1 - The retail-trading platform anticipates that its Robinhood Ventures Fund I will go public in the upcoming weeks [1] - The public listing is expected to occur on the New York Stock Exchange under the ticker symbol RVI [1]

Group 1 - The company states that the settlement would address the majority of outstanding cases related to cancer claims [1] - The Supreme Court has agreed to hear Bayer's appeal aimed at neutralizing these cancer claims [1]